Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 6, 2013, Pages 397-402

  Gandhi, Kunal ^a   Adhikari, Prabha ^a   Basu, Arindam ^a   Achappa, Basavaprabhu ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HSD11B1 GENE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; INDIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SYSTOLE;

EID: 84888024694     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0049     Document Type: Article

References (18)

1. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93(11 Suppl 1):S9-S30.
2. Kanjilal S, Shanker J, Rao VS, et al. Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective. Vasc Health Risk Manag 2008;4:189-197.
3. Pemminati S, Prabha Adhikari MR, Pathak R, et al. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (Boloor Diabetes Study) population of Mangalore. J Assoc Physicians India 2010;58:674-677.
4. Kamble P, Deshmukh PR, Garg N. Metabolic syndrome in adult population of rural Wardha, central India. Indian J Med Res 2010;132:701-705.
5. Nicholas MM Obesity and corticosteroids: 11b-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol 2010;316:154-164.
6. White PC, Mune T, Agarwal AK. 11 b-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135-156.
7. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
8. Morton NM, Paterson JM, Masuzaki H, et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004;53:931-938.
9. Moon SS, Lee YS, Kim JG, et al Relationship of 11b-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes. Endocr J 2011;58:949-959.
10. Gambineri A, Tomassoni F, Munarini A, et al. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. Eur J Endocrinol 2011;165:283-292.
11. Miyamoto Y, Morisaki H, Yamanaka I, et al. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort. Diabetes Res Clin Pract 2009;85:132-138.
12. Robitaille J, Brouillette C, Houde A, et al. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome. Obes Res 2004;12:1570-1575.
13. Caramelli E, Strippoli P, Di Giacomi T, et al. Lack of mutations of type 1 11beta-hydroxysteroid dehydrogenase gene in patients with abdominal obesity. Endocr Res 2001;27:47-61.
14. White PC. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample. J Clin Endocrinol Metab 2005;90:5880-5883.
15. San Millán JL, Botella-Carretero JI, Alvarez-Blasco F, et al. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557ins A polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4157-4162
16. Draper N, Echwald SM, Lavery GG, et al. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002;87:4984-4990.
17. Nair S, Lee YH, Lindsay RS, et al. 11beta-Hydroxysteroid dehydrogenase Type 1: Genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 2004;47:1088-1095.
18. Rankinen T, Perusse L, Weisnagel SJ, et al. The human obesity map: The 2001 update. Obesity Res 2002;10:196-243.